Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi confirmed a sustained overall survival benefit in final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Update on Phase III GY004 trial for cediranib added to Lynparza in platinum-sensitive relapsed ovarian cancer
-
Update on Phase III DANUBE trial for Imfinzi and tremelimumab in unresectable, Stage IV bladder cancer
-
AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicines
-
AstraZeneca divests global rights to Movantik
-
Full-year and Q4 2019 results
-
Brilinta met primary endpoint in Phase III THALES trial in stroke
-
AstraZeneca divests rights to established hypertension medicines
-
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint
-
AstraZeneca to recover the global rights to brazikumab (MEDI2070) from Allergan
Latest articles and press releases
All of our latest press releases and articles are available to explore
